Skip to main content
Clinical Trials/JPRN-UMIN000026097
JPRN-UMIN000026097
Completed
Phase 1

Clinical trial of a new oral plaque removal device using the micro-scale mist - Oral plaque removal test by the micro-scale mist

Tohoku University Graduate School of Dentistry0 sites5 target enrollmentFebruary 16, 2017

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Oral hygiene failure Aspiration pneumonia
Sponsor
Tohoku University Graduate School of Dentistry
Enrollment
5
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Plaque removal test on the tooth surface and safety assessment test on the palate and gingiva were performed on five healthy dentated chin. Regarding the effectiveness of plaque removal, reduction of plaque on the tooth surface was confirmed, but in some cases it could not be said that it is clinically adequate effect, and it is considered that investigation of injection distance and injection time is necessary from now on It was. For safety assessment, it is considered that safety can be secured under the conditions of use in this clinical trial without changing VAS or inflammatory findings in the palate, gums, gingiva and examination of the evaluation of the effectiveness of plaque removal in the palate from now on is necessary. As a future task, confirmation of effectiveness to molar parts and establishment of evaluation index at that time are necessary. No adverse events were observed in the use of this instrument.

Registry
who.int
Start Date
February 16, 2017
End Date
March 17, 2017
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (1\) a person who has a significant malocclusions and periodontal disease (2\) Persons who have periodontal diseases (periodontitis, gingivitis, etc.) of BOP (\+) with periodontal pocket of 5 mm or more in both maxillary middle incisors (3\) Persons with dental caries or medical history on the maxillary both\-side central incisors (4\) a person who has oral mucosal disease (5\) those with vomiting reflex (6\) Other, who one and principal investigator with systemic disease or research team members has judged it difficult to participate in test

Outcomes

Primary Outcomes

Not specified

Similar Trials